AARDEX Group will be at the 2nd value added medicines conference 2018

NOV-2018 : Bernard Vrijens, CEO of AARDEX, is an invited speaker at the 2nd value added medicines

NOV-2018 : Bernard Vrijens, CEO of AARDEX, is an invited speaker at the 2nd value added medicines conference, Brussels, November 21, 2018

This event is organized by Medicines for Europe about ” an innovative approach for patients’ future”.

More on https://www.medicinesforeurope.com/events/vam2018/

Share This Post

You may also like...

Breaking News

Critical momentum: Is medication adherence approaching its universal adoption point?

The ‘Don’t Miss a Moment’ campaign – another chapter in the story of medication adherence Years from now, in a future where healthcare is far more digitally embedded than it is today, the date of 27 March 2025 might well

Oksana Pidmogylna May 8, 2025

Breaking News

Taming the black dog: Managing the challenge of poor adherence among patients with depression

They might not always be easily identifiable, but millions of people across the globe are living with the debilitating symptoms of depression. This common mental disorder is thought to affect around 5% of the world’s adult population, with the pandemic

Oksana Pidmogylna March 20, 2025

AARDEX Group will be at the 2nd value added medicines conference 2018

Share This Post

You may also like...

Critical momentum: Is medication adherence approaching its universal adoption point?

Taming the black dog: Managing the challenge of poor adherence among patients with depression

About

Learn

Solutions

Contact AARDEX Group

USA

Belgium

Switzerland